BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1705406)

  • 1. Pharmacologic manipulation of fetal hemoglobin in the hemoglobinopathies.
    Nathan DG
    Ann N Y Acad Sci; 1990; 612():179-83. PubMed ID: 1705406
    [No Abstract]   [Full Text] [Related]  

  • 2. A cell stress signaling model of fetal hemoglobin induction: what doesn't kill red blood cells may make them stronger.
    Mabaera R; West RJ; Conine SJ; Macari ER; Boyd CD; Engman CA; Lowrey CH
    Exp Hematol; 2008 Sep; 36(9):1057-72. PubMed ID: 18718415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. delta beta-Thalassemia and HPFH.
    Ottolenghi S; Giglioni B; Taramelli R; Comi P; Gianni AM
    Birth Defects Orig Artic Ser; 1982; 18(7):65-7. PubMed ID: 6186314
    [No Abstract]   [Full Text] [Related]  

  • 4. The cellular distribution of fetal hemoglobin: normal adults and hemoglobinopathies.
    Dover GJ; Boyer SH
    Tex Rep Biol Med; 1980-1981; 40():43-54. PubMed ID: 6172872
    [No Abstract]   [Full Text] [Related]  

  • 5. Gene structure in hereditary persistence of fetal hemoglobin individuals.
    Wilson LB; Huisman TH; Wilson JT
    Hemoglobin; 1980; 4(3-4):509-18. PubMed ID: 6158504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The M gamma chain of human fetal hemoglobin.
    Huisman TH; Kutlar F; Kutlar A; Wilson JB; Harris HF
    Prog Clin Biol Res; 1987; 251():507-17. PubMed ID: 2448816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxyurea therapy in highly unstable hemoglobin carriers.
    Rose C; Bauters F; Galacteros F
    Blood; 1996 Oct; 88(7):2807-8. PubMed ID: 8839880
    [No Abstract]   [Full Text] [Related]  

  • 8. Therapeutic approaches to hemoglobin switching in treatment of hemoglobinopathies.
    Stamatoyannopoulos JA; Nienhuis AW
    Annu Rev Med; 1992; 43():497-521. PubMed ID: 1374600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic modulation of fetal globin gene expression in the perinatal period.
    Perrine SP
    Semin Perinatol; 1990 Oct; 14(5):346-50. PubMed ID: 1705052
    [No Abstract]   [Full Text] [Related]  

  • 10. Molecular characterization of hereditary persistence of fetal hemoglobin in a patient from Cuba.
    Martinez G; Hernandez A; Corral L; Muniz A; Alaez C; Serra A; Alfarano A; Saglio G; Camaschella C
    Blood; 1990 Sep; 76(6):1262-3. PubMed ID: 1698103
    [No Abstract]   [Full Text] [Related]  

  • 11. Compound heterozygosity of non-deletional hereditary persistence of fetal hemoglobin and deltabeta-thalassemia.
    Kalamaras A; Chassanidis C; Samara M; Papadakis MN; Vagena A; Aleporou-Marinou V; Patrinos GP; Kollia P
    Am J Hematol; 2008 Sep; 83(9):760. PubMed ID: 18615450
    [No Abstract]   [Full Text] [Related]  

  • 12. Hematological applications: hemoglobinopathies.
    Old JM
    Methods Mol Med; 2004; 92():203-19. PubMed ID: 14733314
    [No Abstract]   [Full Text] [Related]  

  • 13. [Preferential synthesis of fetal hemoglobin in in vitro cultures of erythroid precursors from peripheral blood of healthy persons and those with hemoglobinopathies].
    Efremov GD; Huisman TH
    Bilt Hematol Transfuz; 1979; 7(1 Suppl):39-45. PubMed ID: 95430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The fetal hemoglobin switch in neonatal erythrocytes fractioned on a density gradient].
    Masala B; Demuro P; Formato M; Manca L
    Boll Soc Ital Biol Sper; 1983 Mar; 59(3):278-82. PubMed ID: 9704122
    [No Abstract]   [Full Text] [Related]  

  • 15. Regulation of fetal hemoglobin synthesis by cell cycle specific drugs.
    Nathan DG
    Prog Clin Biol Res; 1985; 191():475-500. PubMed ID: 2413483
    [No Abstract]   [Full Text] [Related]  

  • 16. KLF10 gene expression is associated with high fetal hemoglobin levels and with response to hydroxyurea treatment in β-hemoglobinopathy patients.
    Borg J; Phylactides M; Bartsakoulia M; Tafrali C; Lederer C; Felice AE; Papachatzopoulou A; Kourakli A; Stavrou EF; Christou S; Hou J; Karkabouna S; Lappa-Manakou C; Ozgur Z; van Ijcken W; von Lindern M; Grosveld FG; Georgitsi M; Kleanthous M; Philipsen S; Patrinos GP
    Pharmacogenomics; 2012 Oct; 13(13):1487-500. PubMed ID: 23057549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic induction of fetal hemoglobin production.
    Atweh G; Fathallah H
    Hematol Oncol Clin North Am; 2010 Dec; 24(6):1131-44. PubMed ID: 21075284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human fetal-to-adult globin gene switching in transgenic mice: persistent expression of the G gamma-globin gene in the Japanese HPFH.
    Katsube T; Tojo H; Sakaguchi T; Fukumaki Y
    Biochem Biophys Res Commun; 1993 Jul; 194(1):246-52. PubMed ID: 7687430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of fetal hemoglobin production.
    Kazazian HH
    Semin Hematol; 1974 Oct; 11(4):525-48. PubMed ID: 4608465
    [No Abstract]   [Full Text] [Related]  

  • 20. A transgenic mouse model for studying the induction of fetal hemoglobin in the adult.
    Constantoulakis P; Costantini F; Josephson B; Fry D; Mangahas L; Stamatoyannopoulos G
    Trans Assoc Am Physicians; 1990; 103():80-9. PubMed ID: 1721467
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.